INmune Bio, Inc. (INMB) Earnings
|
Expand Research on INMB
| Next EPS Date | 11/4/26 | EPS Growth Rate | +41.7% |
|---|---|---|---|
| Average EPS % Beat Rate | -8.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/4/26  |
Q326 | N/A | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | -$0.05 | -$0.19 | +$0.14 | N/A | N/A | N/A |  | | Details | |
| 5/7/26 | Q126 | -$0.20 | -$0.27 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 3/11/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A |
